Registry following people treated with neurovascular devices for brain conditions
Follows adults treated with devices for brain aneurysms or ischemic stroke.
Plain-language title generated from the registry record
Registry title: Neurovascular Product Surveillance Registry
Key facts
- Where
- Bratislava, SlovakiaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have been treated, or will be treated, with an approved Medtronic device for an intracranial aneurysm or an acute ischemic stroke.
- Age
- At least 18 years old (an adult under local law)
- Sex
- All sexes can join
- Disease stage
- Intracranial aneurysm or acute ischemic stroke, treated with an approved Medtronic device
- Earlier treatment
- The person has had, or is planned to have, treatment with an eligible Medtronic neurovascular product
Main reasons for not taking part
- Cannot be reached or may not be able to complete follow-up
- Pregnant, breastfeeding, or wishes to become pregnant during the study
- Already in, or planning to join, another drug or device study that could change the results
- Has a contraindication listed in the product's Instructions for Use
- Excluded by local law
Read by machine on 11 November 2026.
Where in Slovakia
- CINRE s.r.o.Bratislava, SlovakiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medtronic Neurovascular Clinical Affairs
- Trial code
- NCT02988128
- Record updated
- 15 September 2026
- Original description
Post market surveillance registryRead full original descriptionShow less
NeuroVascular Product Surveillance Registry (PSR) Platform
Post market surveillance registry
Inclusion: Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements; Patient has, or is intended to receive or be treated with, an eligible Medtronic product; Patient is consented within the enrollment window of the therapy received, as applicable; Patient is at least 18 years of age at time of enrollment.
Exclusion: Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results; Patient is treated or intended to be treated with an eligible Medtronic Neurovascular product; Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results; Additional criteria may be required, refer to cohort-specific Addendum, as applicable, for further guidance; Patient who is, or is expected to be inaccessible for follow-up; Patient with exclusion criteria required by local law; Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study; For MDT24028 and MDT22032:; General Inclusion Criteria:; Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements; Patient is an adult per local law at time of consent. Medtronic Business Restricted This document is electronically controlled CONFIDENTIAL 056-F275 Rev F Clinical Investigation Plan Template; General Exclusion Criteria:; Patient who may be unable to complete the study follow-up; Patient with any contraindications per the applicable Instructions for Use document; Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
For MDT16056 and MDT17077.